267 related articles for article (PubMed ID: 25851712)
1. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
[TBL] [Abstract][Full Text] [Related]
2. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
3. A Low-Grade Myxoid Liposarcoma Arising in a Deep-Seated Conventional Lipoma.
Tsagkozis P; Haglund F
Int J Surg Pathol; 2019 Dec; 27(8):919-922. PubMed ID: 31218893
[TBL] [Abstract][Full Text] [Related]
4. Lipoblastoma-like Tumor of the Vulva, an Important Benign Mimic of Myxoid Liposarcoma.
Creytens D
Int J Gynecol Pathol; 2019 Mar; 38(2):204. PubMed ID: 29300200
[No Abstract] [Full Text] [Related]
5. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
6. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
Murshed KA; Abo Samra H; Ammar A
Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
[TBL] [Abstract][Full Text] [Related]
7. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
[TBL] [Abstract][Full Text] [Related]
8. Mixed-type liposarcoma: clinicopathological, immunohistochemical, and molecular analysis of a case arising in deep soft tissues of the lower extremity.
Mentzel T; Palmedo G; Hantschke M; Woziwodzki J; Beck C
Virchows Arch; 2008 Aug; 453(2):197-201. PubMed ID: 18551309
[TBL] [Abstract][Full Text] [Related]
9. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
10. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
11. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
13. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
14. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
15. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
[TBL] [Abstract][Full Text] [Related]
16. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
[TBL] [Abstract][Full Text] [Related]
17. Myxoid Liposarcoma of the Vulva: A Rare Malignancy Mimicking Benign Vulvar Mass.
Suardi D; Hamdani Z; Palungkun IG; Kireina J; Mantilidewi KI
Am J Case Rep; 2022 Oct; 23():e937575. PubMed ID: 36215216
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.
Watanabe H; Fujishima F; Motoi T; Aoyama Y; Niihori T; Takahashi M; Umegaki S; Oishi H; Tada H; Ichinohasama R; Sasano H
Diagn Pathol; 2022 Dec; 17(1):93. PubMed ID: 36514176
[TBL] [Abstract][Full Text] [Related]
20. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
